Compare Jasa Berdikari Logistics Tbk. (LAJU) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jasa Berdikari Logistics Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Jasa Berdikari Logistics Tbk. trades at Rp70 (market cap 154.8B, 18.06M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Jasa Berdikari Logistics Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| LAJU | SCPI | |
|---|---|---|
Market Cap | 154.8B | 104.4B |
Volume | 18.06M | — |
Lot | 180.61K | — |
Turnover | 1.26B | — |
Average Price | 69.9 | — |
Value | 1.26B | — |
Indicative Equilibrium Price | 70 | — |
Indicative Equilibrium Volume | 3.31K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Jasa Berdikari Logistics Tbk.
PT Jasa Berdikari Logistics Tbk. (the Company) was established based on Notarial Deed No. 55 of Kasir, S.H., dated May 31, 2007. The Company started its commercial operations in 2007. PT Ervin Niaga Abadi is the ultimate parent entity of the Company.
Read more on LAJU →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
